文献速递糖尿病

1型糖尿病孕妇持续葡萄糖监测与新生儿结局的观察性队列研究

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.
PubMed 文献 · Diabetologia · 2019-03-23

该研究纳入瑞典186例1型糖尿病孕妇,分析实时与间歇查看式CGM数据与大于胎龄儿(LGA)及新生儿不良复合结局(NCO)的关联。结果显示,孕中晚期平均葡萄糖升高、标准差增大及目标范围内时间减少与LGA和NCO风险增加相关;尽管全程使用CGM,血糖控制仍不理想,LGA发生率仍高。

要点

  • 孕中晚期平均葡萄糖升高与LGA风险增加独立相关。
  • 目标范围内时间比例越高,LGA和NCO风险越低。
  • 即使全程使用CGM,1型糖尿病孕妇LGA发生率仍高达约半数。

核心结论

  • 孕中晚期平均葡萄糖越高、标准差越大、目标范围内时间越少,LGA和NCO风险越高。
  • 尽管全程使用CGM,日常血糖控制仍不理想,LGA发生率仍高。

研究设计与样本

  • 瑞典1型糖尿病孕妇观察性队列研究,共186例。
  • 使用92台实时CGM和94台间歇查看式CGM的间质葡萄糖数据计算血糖指标。
  • 通过电子病历获取母亲人口学与新生儿结局,采用逐步逻辑回归校正混杂因素。

主要发现

  • 实时CGM与间歇查看式CGM使用者的LGA婴儿数量相似(52% vs 53%)。
  • 孕中期平均葡萄糖与LGA相关(OR 1.53,95% CI 1.12,2.08)。
  • 孕晚期平均葡萄糖与LGA相关(OR 1.57,95% CI 1.12,2.19)。
  • 孕中期目标范围内时间比例与LGA风险降低相关(OR 0.96,95% CI 0.94,0.99)。
  • 孕晚期目标范围内时间比例与LGA风险降低相关(OR 0.97,95% CI 0.95,1.00)。

关键数值与推荐

  • 目标范围定义为3.5-7.8 mmol/l。
  • 计算指标包括平均葡萄糖、SD、CV%、目标范围内时间、平均血糖波动幅度、高血糖指数和低血糖指数。

临床怎么用

  • 对1型糖尿病孕妇应关注孕中晚期平均葡萄糖、血糖变异性和目标范围内时间。
  • 优化目标范围内时间可能有助于降低LGA和NCO风险。
  • 实时CGM使用者低血糖指数更低且低于目标范围时间更少。

局限性

  • 为观察性队列研究,无法确立因果关系。
  • 样本仅来自瑞典,外推性需谨慎。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to analyse patterns of continuous glucose monitoring (CGM) data for associations with large for gestational age (LGA) infants and an adverse neonatal composite outcome (NCO) in pregnancies in women with type 1 diabetes. METHODS: This was an observational cohort study of 186 pregnant women with type 1 diabetes in Sweden. The interstitial glucose readings from 92 real-time (rt) CGM and 94 intermittently viewed (i) CGM devices were used to calculate mean glucose, SD, CV%, time spent in target range (3.5-7.8 mmol/l), mean amplitude of glucose excursions and also high and low blood glucose indices (HBGI and LBGI, respectively). Electronic records provided information on maternal demographics and neonatal outcomes. Associations between CGM indices and neonatal outcomes were analysed by stepwise logistic regression analysis adjusted for confounders. RESULTS: The number of infants born LGA was similar in rtCGM and iCGM users (52% vs 53%). In the combined group, elevated mean glucose levels in the second and the third trimester were significantly associated with LGA (OR 1.53, 95% CI 1.12, 2.08, and OR 1.57, 95% CI 1.12, 2.19, respectively). Furthermore, a high percentage of time in target in the second and the third trimester was associated with lower risk of LGA (OR 0.96, 95% CI 0.94, 0.99 and OR 0.97, 95% CI 0.95, 1.00, respectively). The same associations were found for mean glucose and for time in target and the risk of NCO in all trimesters. SD was significantly associated with LGA in the second trimester and with NCO in the third trimester. Glucose patterns did not differ between rtCGM and iCGM users except that rtCGM users had lower LBGI and spent less time below target. CONCLUSIONS/INTERPRETATION: Higher mean glucose levels, higher SD and less time in target range were associated with increased risk of LGA and NCO. Despite the use of CGM throughout pregnancy, the day-to-day glucose control was not optimal and the incidence of LGA remained high.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kristensen K, Ögge LE, Sengpiel V, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies. Diabetologia. 2019. PMID: 30904938. doi:10.1007/s00125-019-4850-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。